144
Views
11
CrossRef citations to date
0
Altmetric
Review

Cost–effectiveness of Medicare’s coverage of immunosuppression medications for kidney transplant recipients

&
Pages 435-444 | Published online: 09 Jan 2014

References

  • Gaston RS, Giltin MH. Psychological and financial aspects of kidney transplantation. In: Handbook of Kidney Transplantation. Danovitch GM (Ed.). Lippincott Williams and Wilkins, PA, USA (2005).
  • Gordon EJ, Prohaska TR, Seghal AR. The financial impact of immunosuppressant expenses on new kidney transplant recipients. Clin. Transplant.6, 738–748 (2008).
  • Page TF, Woodward RS. Cost of lifetime immunosuppression coverage for kidney transplant recipients. Healthcare Financ. Rev.30(2), 95–104 (2009).
  • Yen EF, Hardinger K, Brennan DC et al. Cost–effectiveness of extending medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am. J. Transplant.4, 1703–1708 (2004).
  • Danovitch GM. Immunosuppressive medicatons and protocols for kidney transplantation. In: Handbook of Kidney Transplantation. Danovitch GM (Ed.). Lippincott Williams and Wilkins, PA, USA (2005).
  • Morton RL, Howard K, Webster AC, Wong G, Craig JC. Cost–effectiveness of induction immunosuppression in kidney transplantation. Nephrol. Dial. Transplant.24, 2258–2269 (2009).
  • Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation49, 372–377 (1990).
  • Shoskes DA, Avelino L, Barba L, Sender M. Patient death or renal graft loss within 3 years of transplantation in a county hospital: importance of poor initial graft function. Clin. Transplant.11, 618–622 (1997).
  • Hong JH, Sumrani N, Delaney V, Dibenedetto A, Butt KM. Cases of late renal allograft failure in the ciclosporine era. Nephron62, 272–279 (1992).
  • Gaston RS, Hudson SL, Ward M, Jones P, Macon R. Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplant. Proc.31, S21–S23 (1999).
  • Goodman WG, Danovitch GM. Options for patients with kidney failure. In: Handbook of Kidney Transplantation. Danovitch GM (Ed.). Lippincott Williams and Wilkins, PA, USA (2005).
  • Feenberg D, Coutts E. An introduction to the TAXSIM model. JPAM12(1), 189–194 (1993).
  • Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL. Effect of extending coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am. J. Transplant.1, 69–73 (2001).
  • Woodward RS, Page TF, Soares R, Schnitzler MA, Lentine KL, Brennan DC. Income-related disparities in kidney transplant graft failures are eliminated by medicare’s immunosuppression coverage. Am. J. Transplant.8, 2636–2646 (2008).
  • Piketty T, Emmanuel S. Income inequality in the United States, 1913–1998. Q. J. Econ.118(1), 1–39 (2003) (series updat, 2008).
  • Kasiske BL, Cohen D, Lucey MR, Neylan JF. Payment for immunosuppression after organ transplantation. J. Am. Med. Assoc.283(18), 24445–24450 (2000).
  • Gordon EJ. Article: sumposium: precious commodities: the supply & demand of body parts: the ethics of medicare policy. De Paul Law Rev.55, 1045 (2006).
  • Viscusi WK, Aldy JE. The value of a statistical life: a critical review of market estimates throughout the world. J. Risk Uncertain.27(1), 5–76 (2003).
  • Ashenfelter Orley. Measuring the value of a statistical life: problems and prospectus. IZA27(1), 5–76 (2006).
  • Neil N, Guest S, Wong L et al. The financial implications for Medicare of greater use of peritoneal dialysis. Clin. Therapeutics31(4), 880–888 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.